-

Battelle Research Pinpoints Local Viral Outbreaks Through Sewage Examination

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle research shows that analyzing wastewater for the presence of the virus that causes COVID-19 can pinpoint specific neighborhoods that are hotspots for viral outbreaks.

A team from Battelle has published a preliminary report based on research conducted last summer. Funded by the National Science Foundation through a COVID-19 rapid response program grant, the pilot test sampled wastewater in Toledo, Ohio throughout the month of July. Led by Senior Genomics Research Scientist Rachel Spurbeck and co-authored by Data Scientist Angela Minard-Smith and Biologist Lindsay Catlin, the paper will appear in “Science of the Total Environment” following peer review.

The findings add to a growing body of scientific work that is helping combat the highly infectious disease, realizing that testing massive amounts of people to find cases can be expensive, time-consuming, inconvenient and complex. By focusing on a neighborhood or facility that’s likely to have an outbreak before testing any individuals, more precise measures to control outbreaks can be taken.

Researchers tested wastewater for the presence of SARS-CoV-2, as well as other pathogens, to help pinpoint specific neighborhoods that were hotspots for infectious disease outbreaks. The team collected effluent from specific manhole locations around the city using 24-hour automatic samplers.

“What’s different about our study is that we sampled effluent from a neighborhood, from a nursing home and from two hospitals to provide a more fine-scale picture of where COVID-19 was present and we have sequenced the COVID-19 to identify viral variants circulating within the city,” said Spurbeck.

This work demonstrates that wastewater-based genomic epidemiology is a tool available to public health agencies in our efforts to contain the virus and end the pandemic, and after the pandemic is over, could be used to monitor other illnesses of public health interest such as gastrointestinal diseases like norovirus or Salmonella.

“This work, when expanded across the country in other cities and neighborhoods, will enable our economy to reopen safely by differentiating regions by SARS-CoV-2 prevalence in a fine-tuned manner,” said Spurbeck. “It will help contact tracing to focus on regions where it is needed and to reduce fear or anxiety where there is little to no viral load.”

About Battelle

Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, and energy and environmental industries. For more information, visit www.battelle.org.

Contacts

Media
Katy Delaney at (614) 424-7208 or delaneyk@battelle.org
or
T.R. Massey at (614) 424-5544 or masseytr@battelle.org

Battelle


Release Versions

Contacts

Media
Katy Delaney at (614) 424-7208 or delaneyk@battelle.org
or
T.R. Massey at (614) 424-5544 or masseytr@battelle.org

More News From Battelle

Battelle Awarded Contract to Advance US Biological Threat Reduction

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has been awarded the Defense Threat Reduction Agency’s (DTRA) Scientific and Technical Engagement Partnership (STEP) 2.0 contract, becoming the sole awardee for this major Biological Threat Reduction (BTR) effort. The award includes a $52.9 million base period, with a total potential value of $93.3 million over the full period of performance. The STEP 2.0 program operates under the Defense Threat Reduction Agency’s (DTRA) Global Threat Reduction (GTR) D...

Battelle Wins New Contract to Continue Environmental Research on Endocrine-disrupting Chemicals

COLUMBUS, Ohio--(BUSINESS WIRE)--The U.S. Environmental Protection Agency recently awarded Battelle one of three blanket purchase agreements to compete for research tasks to evaluate chemicals that may harm the endocrine system in animals and humans. Battelle and two other companies will bid on call orders with a total ceiling value of $44 million over five years to identify potential endocrine-disrupting chemicals and evaluate hazards, exposures, and risks to human health and the environment....

Decorated Senior Army Officer Tal Sullivan Joins Battelle

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle announced today that Tal Sullivan, a highly decorated retired U.S. Army Special Forces (Green Beret) Colonel with more than 30 years of military and leadership experience, has joined the organization as Senior Program Director for Human Performance and Optimization within its Health Research Division. Sullivan brings a distinguished career spanning military operations, program management, and strategic consulting. Most recently, he oversaw major strateg...
Back to Newsroom